A PHASE 1B STUDY OF PEMBROLIZUMAB, IBRUTINIB AND RITUXIMAB IN RECURRENT/REFRACTORY (RR) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

被引:0
|
作者
Chukwueke, Ugonma [1 ]
Wright, Isobel [1 ]
Muzikansky, Alona [2 ]
Russ, Alyssa [1 ]
Fontana, Brittney [1 ]
Kats, Vanessa [1 ]
O'Donnell, Colin [3 ]
Scalfani, Renee [1 ]
Acevedo-Naranjo, Brenda [1 ]
Lee, Eudocia [1 ]
Castro, Luis Nicolas Gonzalez [4 ]
McFaline-Figueroa, Jose Ricardo [4 ]
Aquilanti, Elisa [1 ]
Youssef, Gilbert [4 ]
Beroukhim, Rameen [4 ]
Forst, Deborah [5 ]
Reardon, David
Wen, Patrick [6 ]
Batchelor, Tracy [1 ]
Torres, Alexandra [1 ]
Stefanik, Jennifer [1 ]
Fisher, Jennifer [1 ]
Meredith, David [7 ]
Murakami, Mark [1 ]
Garcia, Yuri [1 ]
Shipp, Margaret [1 ]
Nayak, Lakshmi [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Ctr Neuro Oncol, Boston, MA USA
[5] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Dept Neurol,Div Neurooncol, Boston, MA USA
[6] Brigham & Womens Canc Ctr, Dana Farber, Boston, MA USA
[7] Brigham & Womens Hosp, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CTIM-39
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review
    Nepal, Gaurav
    Khurana, Mahika
    Bucheli, Domenica Herrera
    Bhandari, Siddhartha
    Joshi, Utsav
    Bhagat, Riwaj
    Rehrig, Jessica Holly
    Pudasainee, Prasun
    Shing, Yow Ka
    Ortiz, Juan Fernando
    Ojha, Rajeev
    Gajurel, Bikram Prasad
    Quinonez, Jonathan
    Ruxmohan, Samir
    Albert, Trevine
    Licata, Steven
    Stien, Joel
    NEUROLOGY INTERNATIONAL, 2022, 14 (01): : 99 - 108
  • [22] Treatment with Temozolomide and Ibrutinib in Recurrent/Refractory Primary (PCNSL) and Secondary CNS Lymphoma (SCNSL)
    Renaud, Loic
    Bossard, Jean-Baptiste
    Terriou, Louis
    Cambier, Nathalie
    Chanteau, Guillaume
    Carpentier, Benjamin
    Barbieux, Sarah
    Wemeau, Mathieu
    Hieulle, Julia
    Boyle, Eileen M.
    Morschhauser, Franck
    BLOOD, 2020, 136
  • [23] Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
    Renaud, Loic
    Bossard, Jean Baptiste
    Carpentier, Benjamin
    Terriou, Louis
    Cambier, Nathalie
    Chanteau, Guillaume
    Escure, Guillaume
    Tilmont, Remi
    Barbieux, Sarah
    Wemeau, Mathieu
    Hieulle, Julia
    Boyle, Eileen M.
    Morschhauser, Franck
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (03) : 370 - 373
  • [24] Recurrent primary central nervous system lymphoma (PCNSL) complicated by lymphomatous metastases (LM)
    Glantz, M
    Kormanik, P
    Chamberlain, MC
    NEUROLOGY, 1998, 50 (04) : A269 - A269
  • [25] Emavusertib (CA-4948) in combination with ibrutinib in patients with relapsed/refractory primary central nervous system lymphoma (R/R PCNSL)
    Grommes, Christian
    Tun, Han W.
    Burguera, Adolfo de la Fuente
    Dabrowska-iwanicka, Anna
    Regales, Lucia
    Zhao, Wanying
    Ferrari, Dora
    Fowles, Meaghan
    Lane, Maureen E.
    Wang, Catherine
    Von Roemeling, Reinhard W.
    Taszner, Michal
    D'angelo, Christopher
    Nowakowski, Grzegorz S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
    Grommes, Christian
    Tang, Sarah S.
    Wolfe, Julia
    Kaley, Thomas J.
    Daras, Mariza
    Pentsova, Elena I.
    Piotrowski, Anna F.
    Stone, Jacqueline
    Lin, Andrew
    Nolan, Craig P.
    Manne, Malbora
    Codega, Paolo
    Campos, Carl
    Viale, Agnes
    Thomas, Alissa A.
    Berger, Michael F.
    Hatzoglou, Vaios
    Reiner, Anne S.
    Panageas, Katherine S.
    DeAngelis, Lisa M.
    Mellinghoff, Ingo K.
    BLOOD, 2019, 133 (05) : 436 - 445
  • [27] Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma.
    Grommes, Christian
    Stone, Jacqueline
    Nolan, Craig
    Tsyvkin, Elina
    Wolfe, Julia
    Mellinghoff, Ingo K.
    DeAngelis, Lisa Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Phase II Study of Rituximab Given in Conjunction with Standard Chemotherapy in Primary Central Nervous System Lymphoma (PCNSL)[E1F05]
    Swinnen, Lode J.
    O'Neill, Anne
    Imus, Philip H.
    Gujar, Sachin
    Schiff, David
    Kleinberg, Lawrence
    Advani, Ranjana
    Dunbar, Erin
    Moore, Dennis F., Jr.
    Grossman, Stuart
    BLOOD, 2015, 126 (23)
  • [29] Primary central nervous system lymphoma (PCNSL) in older patients
    Bertucci, Alexandre
    Harlay, Vincent
    Chinot, Olivier
    Tabouret, Emeline
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (05) : 373 - 381
  • [30] Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL)
    Nelson, DF
    JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (03) : 241 - 247